GMED 클래스 A Globus Medical, Inc. Class A Common Stock
NYSE · Health Care · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 8월 6, 2026GMED 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
GMED 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
Globus Medical, Inc. Class A Common Stock 정보 위키백과 회사 개요
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | GMED | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E (TTM) | 19.45년 평균 ≈54.5 | ≈54.5 | 28.6 | 저평가 | |
| PEG Ratio (PEG 비율) | ≈0.6 | · | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | GMED | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 영업이익률 (TTM) | 20.3%5년 평균 ≈12.3% | ≈12.3% | 13.1% | 최상위권 | |
| EBITDA 마진 (TTM) | 29.2%5년 평균 ≈21.3% | ≈21.3% | 13.7% | 최상위권 | |
| 세전 마진 (TTM) | 21.0%5년 평균 ≈13.7% | ≈13.7% | 11.8% | 최상위권 | |
| 순이익률 (TTM) | 17.0%5년 평균 ≈11.4% | ≈11.4% | 9.0% | 최상위권 | |
| ROA (TTM) | 10.2%5년 평균 ≈6.0% | ≈6.0% | 4.6% | 최상위권 | |
| ROE (TTM) | 11.8%5년 평균 ≈6.6% | ≈6.6% | 8.9% | 최상위권 | |
| ROIC | 9.3%5년 평균 ≈5.8% | ≈5.8% | 7.1% | 최상위권 |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | GMED | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 유동비율 (MRQ) | 4.65년 평균 ≈4.5 | ≈4.5 | 2.4 | 강한 유동성 | |
| 당좌 비율 (MRQ) | 2.75년 평균 ≈1.9 | ≈1.9 | 1.0 | 강한 유동성 |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | GMED | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | 16.7%5년 평균 ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | 42.2%5년 평균 ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | 30.1% | · | · | · | |
| EPS YoY | 422.7%5년 평균 ≈84.3% | ≈84.3% | · | · | |
| Net Income YoY (순이익 YoY) | 422.3%5년 평균 ≈88.8% | ≈88.8% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3년) | 28.4%5년 평균 ≈3.6% | ≈3.6% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5년) | 31.2% | · | · | · | |
| Net Income CAGR 3Y (순이익 CAGR 3년) | 41.4%5년 평균 ≈12.0% | ≈12.0% | · | · | |
| Net Income CAGR 5Y (순이익 CAGR 5년) | 39.4% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | GMED | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 0.65년 평균 ≈0.5 | ≈0.5 | 0.5 | 동일 | |
| Inventory Turnover (재고 회전율) | 1.45년 평균 ≈1.2 | ≈1.2 | 1.8 | 약함 | |
| Receivables Turnover (매출 채권 회전율) | 4.85년 평균 ≈5.0 | ≈5.0 | 6.2 | 약함 | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$489.8K | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | 8월 5, 2026 | $1.34 | $1.12 | 19.5% |
| 2026년 3월 31일 | 5월 12, 2026 | $1.12 | $0.94 | 19.4% |
| 2025년 12월 31일 | $1.28 | $1.17 | 9.2% | |
| 2025년 9월 30일 | $1.18 | $0.80 | 47.8% | |
| 2025년 6월 30일 | $0.86 | $0.77 | 11.6% | |
| 2025년 3월 31일 | $0.68 | $0.76 | -10.4% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
대차대조표
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
현금 흐름
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
수익성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
유동성 및 지급능력
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
효율성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
주당
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $14.05 | $12.03 | $10.01 | $8.67 | $7.50 | $6.18 | |
| Revenue / Share | $21.44 | $18.27 | $13.68 | · | $9.25 | $7.81 | $7.70 | $7.04 | $6.50 | $5.85 | $5.67 | $4.97 | |
| Cash Flow / Share | $5.50 | $3.78 | $2.12 | · | $2.67 | $1.97 | $1.69 | $1.79 | $1.63 | $1.78 | $1.27 | $0.83 | |
| Cash / Share | · | · | · | · | · | · | $1.96 | $1.42 | $1.23 | $1.38 | $0.63 | $0.87 | |
| EPS (TTM) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 |
성장률
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
손익계산서
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | · | 134,502,000 | 135,205,000 | 136,757,000 | · | 135,615,000 | 135,195,000 | 135,358,000 | · | 113,537,000 | 100,373,000 | 100,279,000 | · | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | · | 135,394,000 | 136,499,000 | 139,774,000 | · | 138,062,000 | 136,979,000 | 135,358,000 | · | 115,245,000 | 101,782,000 | 102,196,000 | · | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
대차대조표
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
현금 흐름
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
수익성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
유동성 및 지급능력
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
효율성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
주당
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.75 | $5.50 | · | $5.68 | $5.46 | $4.28 | · | $4.53 | $4.60 | $4.48 | · | $3.33 | $2.87 | $2.71 | · | $2.51 | |
| Cash Flow / Share | · | $1.46 | · | · | · | $1.27 | · | · | · | $0.39 | · | · | · | $0.52 | · | · | |
| EPS (TTM) | $3.89 | $4.28 | · | $3.10 | $2.60 | $1.34 | · | $0.57 | $0.20 | $0.54 | · | $1.54 | $2.00 | $1.96 | · | $1.52 |
가치 평가 (TTM)
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.14B | $3.10B | · | $2.77B | $2.63B | $2.51B | · | $2.48B | $2.24B | $1.90B | · | $1.23B | $1.10B | $1.07B | · | $998M | |
| Net Income TTM | $535M | $587M | · | $424M | $357M | $186M | · | $92M | $41M | $67M | · | $158M | $204M | $201M | · | $155M | |
| P/E | 20.3 | 20.1 | · | 18.5 | 22.7 | 54.6 | · | 125.5 | 342.4 | 99.3 | · | 32.2 | 29.8 | 28.9 | · | 39.2 | |
| Earnings Yield | 4.9% | 5.0% | · | 5.4% | 4.4% | 1.8% | · | 0.80% | 0.29% | 1.0% | · | 3.1% | 3.4% | 3.5% | · | 2.5% |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 매출 | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| 매출 총이익률 % | · | · | 65.0% | · | 75.0% |
| 영업이익률 % | 16.3% | 6.6% | 8.5% | · | 17.9% |
| 순이익 | $538M | $103M | $123M | $190M | $149M |
| 희석 EPS | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 유동비율 | 4.3 | 2.5 | 4.9 | · | 6.2 |
| 당좌 비율 | 2.5 | 0.8 | 1.4 | · | 3.0 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $589M | $405M | $165M | · | $219M |
기관 투자자 (13F) 639개의 제출자 · $10.4B 전체 · 기준일 2026년 9월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 76 (-42 이전 분기 대비) | 82 (+32 이전 분기 대비) | 254 (+26 이전 분기 대비) | 180 (0 이전 분기 대비) | +5.4M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $921,072,916 | 10,549,455 | 8.82% | 주식 |
| BlackRock, Inc. | $853,839,261 | 10,806,724 | 8.18% | 주식 |
| JANUS HENDERSON GROUP PLC | $656,831,032 | 7,623,095 | 6.29% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $403,546,103 | 5,107,532 | 3.86% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394,606,359 | 4,994,385 | 3.78% | 주식 |
| Invesco Ltd. | $340,515,006 | 4,309,771 | 3.26% | 주식 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338,141,467 | 4,279,730 | 3.24% | 주식 |
| STATE STREET CORP | $293,540,630 | 3,714,029 | 2.81% | 주식 |
| Sculptor Capital LP | $237,030,000 | 3,000,000 | 2.27% | 주식 |
| JPMORGAN CHASE & CO | $230,761,440 | 2,743,850 | 2.21% | 주식 |
| Burgundy Asset Management Ltd. | $212,054,428 | 3,460,983 | 2.03% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $205,090,439 | 2,380,344 | 1.96% | 주식 |
| BANK OF MONTREAL /CAN/ | $191,638,042 | 2,425,491 | 1.83% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $187,250,224 | 2,369,310 | 1.79% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $170,151,584 | 2,153,014 | 1.63% | 주식 |
| GOLDMAN SACHS GROUP INC | $140,764,853 | 1,781,608 | 1.35% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135,630,225 | 1,716,621 | 1.30% | 주식 |
| Boston Trust Walden Corp | $124,311,253 | 1,573,361 | 1.19% | 주식 |
| Boston Partners | $122,847,510 | 1,554,990 | 1.18% | 주식 |
| Allspring Global Investments Holdings, LLC | $119,384,889 | 1,571,681 | 1.14% | 주식 |
| GENEVA CAPITAL MANAGEMENT LLC | $111,962,440 | 1,417,067 | 1.07% | 주식 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101,519,633 | 1,284,896 | 0.97% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $98,471,901 | 1,246,322 | 0.94% | 주식 |
| Quantinno Capital Management LP | $96,320,933 | 1,219,098 | 0.92% | 주식 |
| NORGES BANK | $89,048,300 | 1,127,051 | 0.85% | 주식 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88,055,393 | 1,114,484 | 0.84% | 주식 |
| MORGAN STANLEY | $86,496,544 | 1,094,753 | 0.83% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84,736,329 | 1,072,476 | 0.81% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $81,207,111 | 1,027,808 | 0.78% | 주식 |
| WELLS FARGO & COMPANY/MN | $78,742,680 | 996,617 | 0.75% | 주식 |
| Madison Avenue Partners, LP | $73,891,416 | 935,216 | 0.71% | 주식 |
| ANTIPODES PARTNERS Ltd | $71,581,796 | 905,984 | 0.69% | 주식 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $70,042,286 | 886,499 | 0.67% | 주식 |
| NORTHERN TRUST CORP | $69,578,813 | 880,633 | 0.67% | 주식 |
| AXA Investment Managers S.A. | $68,885,959 | 1,202,828 | 0.66% | 주식 |
| Global Alpha Capital Management Ltd. | $67,681,230 | 856,616 | 0.65% | 주식 |
| Vestal Point Capital, LP | $67,158,500 | 850,000 | 0.64% | 주식 |
| UBS Group AG | $65,909,432 | 834,191 | 0.63% | 주식 |
| Bank of New York Mellon Corp | $61,258,598 | 775,328 | 0.59% | 주식 |
| FMR LLC | $60,683,705 | 768,051 | 0.58% | 주식 |
| BANK OF AMERICA CORP /DE/ | $58,239,298 | 737,113 | 0.56% | 주식 |
| Stephens Investment Management Group LLC | $57,159,864 | 723,451 | 0.55% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $56,575,822 | 716,059 | 0.54% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $54,970,813 | 695,745 | 0.53% | 주식 |
| Clark Capital Management Group, Inc. | $54,271,890 | 686,899 | 0.52% | 주식 |
| AMERICAN CAPITAL MANAGEMENT INC | $51,599,219 | 653,072 | 0.49% | 주식 |
| ANCHOR CAPITAL ADVISORS LLC | $51,225,201 | 648,338 | 0.49% | 주식 |
| Camber Capital Management LP | $47,216,000 | 800,000 | 0.45% | 주식 |
| Capital World Investors | $46,664,254 | 590,612 | 0.45% | 주식 |
| Artemis Investment Management LLP | $45,305,914 | 573,420 | 0.43% | 주식 |
회사 내부자 22 명의 내부자 · 11 임원 · 15 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 2026년 1월 21일 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 2025년 1월 23일 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 2022년 1월 27일 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 2026년 1월 21일 A | 0 | 0 | 2 | $-2,032,133 |
| Richard A Baron | Senior VP and CFO | 2014년 5월 2일 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 2019년 3월 7일 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 2026년 2월 25일 M | 0 | 0 | 3 | $-3,441,700 |
| David C Paul | Executive Chairman | 2026년 1월 21일 A | 60,417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 2019년 2월 1일 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 2018년 6월 25일 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2018년 2월 2일 A | 35,217 | 0 | 0 | $0 |
| James R Tobin | 이사 | 2026년 9월 15일 M | 0 | 0 | 1 | $-2,237,400 |
| Stephen T Zarrilli | 이사 | 2026년 8월 18일 M | 0 | 0 | 2 | $-4,283,250 |
| David D Davidar | 이사 | 2026년 7월 27일 G | 507,675 | 0 | 2 | $-4,169,000 |
| Ann D Rhoads | 이사 | 2026년 6월 4일 M | 40,384 | 0 | 2 | $-818,000 |
| Dan Wolterman | 이사 | 2026년 1월 21일 A | 24,025 | 0 | 0 | $0 |
| Leslie V Norwalk | 이사 | 2026년 1월 21일 A | 10,419 | 0 | 2 | $-557,600 |
| Dan Lemaitre | 이사 | 2026년 1월 21일 A | 0 | 0 | 0 | $0 |
| John A Deford | 이사 | 2026년 1월 21일 A | 15,578 | 0 | 0 | $0 |
| Robert Andrew Douglas | 이사 | 2026년 1월 21일 A | 2,005 | 0 | 0 | $0 |
| Kurt Wheeler | 이사 | 2019년 1월 22일 A | 44,319 | 0 | 0 | $0 |
| Robert Liptak | 이사 | 2019년 1월 22일 A | 26,159 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 69 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2.90% | 16,797 NS | 2026년 7월 31일 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.26% | 300,351 NS | 2026년 7월 31일 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1.83% | 122,008 SH | 2026년 10월 2일 | 일간 |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.52% | 13,339 NS | 2026년 7월 31일 | N-PORT |
| BUL · Pacer Funds Trust | 1.37% | 22,796 NS | 2026년 7월 31일 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1.35% | 340,460 NS | 2026년 7월 31일 | N-PORT |
| IHI · iShares Trust | 1.25% | 541,723 SH | 2026년 9월 11일 | 일간 |
| RFG · Invesco Exchange-Traded Fund Trust | 0.81% | 36,501 SH | 2026년 10월 2일 | 일간 |
| MCOW · Pacer Funds Trust | 0.68% | 92 NS | 2026년 7월 31일 | N-PORT |
| SMDX · Tidal Trust III | 0.58% | 9,542 NS | 2026년 7월 31일 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0.50% | 13,493 SH | 2026년 10월 2일 | 일간 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.47% | 111,810 SH | 2026년 8월 19일 | 일간 |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 20,104 NS | 2026년 7월 31일 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.32% | 23,234 NS | 2026년 7월 31일 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.30% | 16,476 SH | 2026년 10월 2일 | 일간 |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.29% | 16,839 NS | 2026년 7월 31일 | N-PORT |
| ISCG · iShares Trust | 0.28% | 35,968 SH | 2026년 9월 11일 | 일간 |
| BKMC · BNY Mellon ETF Trust | 0.27% | 22,533 NS | 2026년 7월 31일 | N-PORT |
| PTMC · Pacer Funds Trust | 0.25% | 12,456 NS | 2026년 7월 31일 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.25% | 183,180 SH | 2026년 8월 19일 | 일간 |
| VBK · VANGUARD INDEX FUNDS | 0.24% | 1,499,816 SH | 2026년 8월 19일 | 일간 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 49,674 NS | 2026년 7월 31일 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.19% | 1,664 NS | 2026년 7월 31일 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 57,770 NS | 2026년 7월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.15% | 284,148 NS | 2026년 7월 31일 | N-PORT |
| IYH · iShares Trust | 0.13% | 65,761 SH | 2026년 9월 11일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.13% | 338,547 SH | 2026년 8월 19일 | 일간 |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.13% | 22,085 SH | 2026년 10월 2일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 53,700 NS | 2026년 7월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.13% | 245,718 NS | 2026년 7월 31일 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0.12% | 39,173 NS | 2026년 7월 31일 | N-PORT |
| SMMD · iShares Trust | 0.11% | 59,918 SH | 2026년 9월 11일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.11% | 2,596,850 SH | 2026년 8월 19일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.10% | 1,300,059 SH | 2026년 8월 19일 | 일간 |
| VFMF · VANGUARD WELLINGTON FUND | 0.10% | 8,946 SH | 2026년 8월 19일 | 일간 |
| DFSV · Dimensional ETF Trust | 0.10% | 103,731 NS | 2026년 7월 31일 | N-PORT |
| INFO · Harbor ETF Trust | 0.10% | 10,513 NS | 2026년 7월 31일 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 10,277 SH | 2026년 10월 2일 | 일간 |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.10% | 6,977 NS | 2026년 7월 31일 | N-PORT |
| IWS · iShares Trust | 0.08% | 166,482 SH | 2026년 9월 11일 | 일간 |
| WSML · iShares Trust | 0.08% | 6,832 SH | 2026년 9월 11일 | 일간 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.07% | 13,036 NS | 2026년 7월 31일 | N-PORT |
| IWR · iShares Trust | 0.06% | 458,676 SH | 2026년 9월 11일 | 일간 |
| DFUV · Dimensional ETF Trust | 0.04% | 87,854 NS | 2026년 7월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.04% | 2,717 NS | 2026년 7월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.03% | 205,429 NS | 2026년 7월 31일 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.03% | 20,026 SH | 2026년 10월 2일 | 일간 |
| DFSU · Dimensional ETF Trust | 0.03% | 8,925 NS | 2026년 7월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.03% | 11,916 NS | 2026년 7월 31일 | N-PORT |
| IUSG · iShares Trust | 0.02% | 99,439 SH | 2026년 9월 11일 | 일간 |
| IWD · iShares Trust | 0.02% | 248,750 SH | 2026년 9월 11일 | 일간 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 67,710 SH | 2026년 8월 19일 | 일간 |
| ESGV · VANGUARD WORLD FUND | 0.02% | 25,284 SH | 2026년 8월 19일 | 일간 |
| DFAU · Dimensional ETF Trust | 0.02% | 27,167 NS | 2026년 7월 31일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 38,185 NS | 2026년 7월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3,476 NS | 2026년 7월 31일 | N-PORT |
| IYY · iShares Trust | 0.01% | 4,949 SH | 2026년 9월 11일 | 일간 |
| IWB · iShares Trust | 0.01% | 77,825 SH | 2026년 9월 11일 | 일간 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.01% | 15,270 SH | 2026년 10월 2일 | 일간 |
| ITOT · iShares Trust | 0.01% | 145,193 SH | 2026년 9월 11일 | 일간 |
| IWV · iShares Trust | 0.01% | 30,738 SH | 2026년 9월 11일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3,596,212 SH | 2026년 8월 19일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 89,702 SH | 2026년 8월 19일 | 일간 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 18,804 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,508 SH | 2026년 8월 19일 | 일간 |
| IJH · iShares Trust | · | 3,976,473 SH | 2026년 9월 11일 | 일간 |
| IJK · iShares Trust | · | 657,157 SH | 2026년 9월 11일 | 일간 |
| XJH · iShares Trust | · | 15,479 SH | 2026년 9월 8일 | 일간 |
| ISCB · iShares Trust | · | 5,094 SH | 2026년 9월 11일 | 일간 |
GMED 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
12개월 목표 주가
13 명의 애널리스트 · 2026-10-03평균 목표 $100.92 +33.5%
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
트레이딩 시그널 진입 가격 및 위험/보상 비율을 포함한 최근 매수/매도 신호
현재 열린 신호가 없습니다 — 카드가 채워지지 않았으며, 이는 정직한 것입니다.
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.